- Profesionales
- Research
- Studies/Publications
- HER2 positive Breast Cancer
- Metastatic
- Closed
- GEICAM/2001-07_BCIRG007
HER2 positive Breast Cancer
GEICAM/2001-07_BCIRG007
A multicenter phase III randomized trial comparing Docetaxel (Taxotere) and Trastuzumab (Herceptin) with Docetaxel (Taxotere), Carboplatin and Trastuzumab (Herceptin) as first line chemotherapy for patients with advanced Breast Cancer containing the HER2 gene amplification
Medical Coordinator:
Dr. Miguel Martín Jiménez
Included Patients:
12
Global:
263
Sponsor:
Jonsson Comprehensive Cancer Center
Link:
https://clinicaltrials.gov/ct2/show/NCT00047255?term=BCIRG007&rank=1